ELAN Elanco Animal Health Inc

Price (delayed)

$32.185

Market cap

$15.22B

P/E Ratio

N/A

Dividend/share

N/A

EPS

-$1.55

Enterprise value

$20.74B

Elanco Animal Health Incorporated is an American pharmaceutical company which produces medicines and vaccinations for pets and livestock. Until 2019, the company was a subsidiary of Eli Lilly and Company, ...

Highlights
The gross profit has soared by 71% YoY and by 22% from the previous quarter
Elanco Animal Health's revenue has soared by 62% YoY and by 18% from the previous quarter
The quick ratio has plunged by 64% YoY but it has grown by 9% from the previous quarter
The debt has soared by 197% year-on-year
Elanco Animal Health's net income has decreased by 27% from the previous quarter

Key stats

What are the main financial stats of ELAN
Market
Shares outstanding
473.02M
Market cap
$15.22B
Enterprise value
$20.74B
Valuations
Price to earnings (P/E)
N/A
Price to book (P/B)
1.91
Price to sales (P/S)
3.45
EV/EBIT
N/A
EV/EBITDA
183.71
EV/Sales
4.56
Earnings
Revenue
$4.55B
EBIT
-$613.6M
EBITDA
$112.9M
Free cash flow
-$278.4M
Per share
EPS
-$1.55
Free cash flow per share
-$0.57
Book value per share
$16.87
Revenue per share
$9.34
TBVPS
$9.93
Balance sheet
Total assets
$16.83B
Total liabilities
$8.85B
Debt
$6.1B
Equity
$7.98B
Working capital
$1.44B
Liquidity
Debt to equity
0.76
Current ratio
1.72
Quick ratio
0.88
Net debt/EBITDA
48.87
Margins
EBITDA margin
2.5%
Gross margin
52.6%
Net margin
-16%
Operating margin
-12.5%
Efficiency
Return on assets
-4.2%
Return on equity
-8.9%
Return on invested capital
-7.2%
Return on capital employed
-4.1%
Return on sales
-13.5%
Dividend
Dividend yield
N/A
DPS
N/A
Payout ratio
N/A

ELAN stock price

How has the Elanco Animal Health stock price performed over time
Intraday
-0.88%
1 week
-3.58%
1 month
1.53%
1 year
17.68%
YTD
4.94%
QTD
-7.22%

Financial performance

How have Elanco Animal Health's revenue and profit performed over time
Revenue
$4.55B
Gross profit
$2.39B
Operating income
-$566.8M
Net income
-$728.8M
Gross margin
52.6%
Net margin
-16%
The gross profit has soared by 71% YoY and by 22% from the previous quarter
Elanco Animal Health's revenue has soared by 62% YoY and by 18% from the previous quarter
Elanco Animal Health's operating income has decreased by 28% from the previous quarter
Elanco Animal Health's net income has decreased by 27% from the previous quarter

Growth

What is Elanco Animal Health's growth rate over time

Valuation

What is Elanco Animal Health stock price valuation
P/E
N/A
P/B
1.91
P/S
3.45
EV/EBIT
N/A
EV/EBITDA
183.71
EV/Sales
4.56
The company's EPS fell by 24% QoQ
ELAN's equity is up by 20% YoY
The price to book (P/B) is 13% higher than the last 4 quarters average of 1.7
Elanco Animal Health's revenue has soared by 62% YoY and by 18% from the previous quarter
ELAN's P/S is 13% below its last 4 quarters average of 4.0

Efficiency

How efficient is Elanco Animal Health business performance
Elanco Animal Health's ROE has decreased by 22% from the previous quarter
The company's return on assets fell by 14% QoQ
Elanco Animal Health's ROIC has decreased by 11% from the previous quarter
The company's return on sales fell by 6% QoQ

Dividends

What is ELAN's dividend
DPS
N/A
Dividend yield
N/A
Payout ratio
N/A

There are no recent dividends present for ELAN.

Financial health

How did Elanco Animal Health financials performed over time
Elanco Animal Health's total assets is 90% higher than its total liabilities
The company's total liabilities has surged by 175% YoY
Elanco Animal Health's total assets has surged by 70% YoY
The debt is 24% smaller than the equity
The debt has soared by 197% year-on-year
The debt to equity has surged by 145% year-on-year

All financial data is based on trailing twelve months (TTM) periods - updated quarterly, unless otherwise specified.